Jiangsu Hengrui Medicine Co., Ltd. (SHA: 600276)

Jiangsu Hengrui Medicine Revenue

Jiangsu Hengrui Medicine had revenue of 6.59B CNY in the quarter ending September 30, 2024, with 12.72% growth. This brings the company's revenue in the last twelve months to 26.00B, up 16.34% year-over-year. In the year 2023, Jiangsu Hengrui Medicine had annual revenue of 22.82B with 7.26% growth.

• Revenue (ttm): 26.00B
• Revenue Growth: +16.34%
• P/S Ratio: 12.23
• Revenue / Employee: 1.33M
• Employees: 19,611
• Market Cap: 319.14B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	22.82B	1.54B	7.26%
Dec 31, 2022	21.28B	-4.63B	-17.87%
Dec 31, 2021	25.91B	-1.83B	-6.59%
Dec 31, 2020	27.73B	4.45B	19.09%
Dec 31, 2019	23.29B	5.87B	33.70%